Evidence map›Paper›PMID 41926583›Full record

ArticleScience (New York, N.Y.)2026

Mitochondrial metabolism and signaling direct dendritic cell function in antitumor immunity.

Zhiyuan You, Jiyeon Kim, Chuansheng Guo, Haoran Hu, Nicole M Chapman, Xiaoxi Meng, Hao Shi, Yan Wang, Cliff Guy, Anil Kc and 6 more

Abstract read
In one paragraph

Article in Science (New York, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Zhiyuan You *Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID 0000-0001-9833-7485
Jiyeon Kim *Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID 0000-0003-0537-838X
Chuansheng GuoDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Haoran HuDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Nicole M ChapmanDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID 0000-0003-4710-1776
Xiaoxi MengDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID 0000-0001-7217-2037
Hao ShiDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID 0000-0002-2796-629X
Yan WangDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID 0000-0003-4779-9967
Cliff GuyDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID 0000-0001-7486-7107
Anil KcDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Jia LiDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Jordy SaraviaDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID 0000-0002-2691-501X
Gustavo PalaciosDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID 0009-0001-2483-3774
Sherri RankinDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Camenzind G RobinsonCell and Tissue Imaging Center, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID 0000-0002-7277-692X
Hongbo ChiDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID 0000-0002-9997-2496

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Shondra Michelle Miller · 1985 to 2026
$166.9M
Integrating systems immunology with immunometabolism and cancer immunityR35CA253188 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Hongbo Chi · 2021 to 2026
$6.0M
Metabolic checkpoint in TH17 cell differentiationR01AI105887 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHI, HONGBO · 2014 to 2018
$2.2M
NCI NIH HHS P30 CA021765NCI NIH HHS R35 CA253188NIAID NIH HHS R01 AI105887
6 · The paper itself

Abstract

Antitumor immunity requires conventional type 1 dendritic cells (cDC1s). How cDC1s maintain functional fitness in the tumor microenvironment remains unclear. In this study, we established that intratumoral cDC1s exhibited discrete mitochondrial states and that OPA1-mediated mitochondrial energy and redox metabolism dictated cDC1 antitumor responses. Mechanistically, OPA1 orchestrated antigen presentation and the CD8

Indexed as

Dendritic CellsMitochondriaNeoplasmsAnimalsAntigen PresentationCD8-Positive T-LymphocytesCell Line, TumorEnergy MetabolismGTP PhosphohydrolasesImmunotherapyMembrane Potential, MitochondrialMiceMice, Inbred C57BLNADOxidation-ReductionSignal TransductionGTP PhosphohydrolasesNADOpa1 protein, mouse

Identifiers

PMID41926583
PMCPMC13109015

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.